The Advisory Team at Reset Pharmaceuticals provides expert guidance on the development and commercialization of novel psychedelic treatments. Comprised of Scientific and Strategic Advisors, the team offers insights on research methodologies, regulatory pathways, market strategies, and partnership opportunities to advance Reset Pharma's mission.
Benjamin Kelmendi
Scientific Advisor
Brad Sitko
Strategic Advisor
David Hellerstein
Scientific Advisor
Gilbert Block
Scientific Advisor
Harvey Max Chochinov
Scientific Advisor
Jim Grigsby
Scientific Advisor
Mark Corrigan
Strategic Advisor
Peter Hendricks
Scientific Advisor
Richard A. Yacenda
Strategic Advisor
Stephen Juelsgaard
Strategic Advisor
View all